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Wereportthecaseofa57-year-oldwomansuﬀeringfromcongestiveheartfailure.Duetorefractorycongestionsdespiteoptimised
medical treatment, the patient was listed for heart transplantation and peritoneal dialysis was initiated. Peritoneal dialysis led to
a signiﬁcant weight loss, reduction of hyperhydration and extracellular water obtained by bioimpedance measurement, and a
signiﬁcant improvement in clinical and echocardiographic examination. Furthermore, residual kidney function increased during
the long-term followup, and subsequently peritoneal dialysis was ceased. Pulmonary artery pressure and left ventricular ejection
fraction remained stable and the patient did well. This case demonstrates the possibility of treating hyperhydration due to
congestive heart failure with peritoneal dialysis resulting in recompensation of both heart and kidney functions.
1.Background
Chronic congestive heart failure is an entity that may lead
to progressive chronic kidney disease, then classiﬁed as cardi
orenal syndrome type 2 [1]. The pathophysiology of renal
dysfunction in the setting of advanced cardiac failure is not
yet well understood; however, haemodynamic issues seem
to play an important role, as well as renal congestion and
neurohormonalabnormalities.Amajorprobleminthetreat-
ment of cardiorenal syndrome type 2 is the progression of
renal injury due to optimised drug therapies of cardiac fail-
ure, such as loop diuretics. The treatment of refractory con-
gestive heart failure with peritoneal dialysis has been intro-
duced in the late 40s [2] but has not yet become a stand-
ardized approach [3].
2.CaseReport
This concerns a 57-year-old female patient, who introduced
herself in 2002 for the ﬁrst time in our outpatient clinic. At
that point, an anterior myocardial infarction of unknown
duration and a posterior myocardial infarction in 10/02
treated with double aortocoronary bypass were already
known.
After accurate diagnostics, an ischaemic cardiomyopathy
with a high-level constriction of the left ventricular ejection
fraction (26% measured in TTE), a 3-vessel coronary artery
disease, an insuﬃcient mitral valve I◦, an arterial hyperten-
sion, and hyperlipidaemia were recognised. As a result of
triggerable ventricular extrasystoles, an AICD was implanted
in 11/02.
In 7/2007, an infarction of the cerebri media artery led to
a brachiofacial hemiparesis in the right territorial area with
dysarthria and dysphagia on the left side. In 11/07, an ICD-
CAT upgrade was accomplished.
In Spring 2008, in a status of repeated hydropic decom-
pensation,thepatientarrivedagainforadmissiontoevaluate
the possibility of a heart transplantation. After intensive and
multidisciplinary discussion, the decision to wait-list the pa-
tient was reached despite the present comorbidities.
At this time, the cardiac capacity was very low with a
maximum possible walking distance of 25 metres.
The clinical status worsened in June 2008 when there was
a recrudescence of cardiac decompensation with hyperhy-
dration, although maximal possible medical treatment was
administered. The indication for dialysis had arisen, because
ofarepeatedhydropicdecompensationandaplainlyreduced2 Case Reports in Medicine
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Figure 1: (a) Time course of pulmonary artery pressure (PAP),
left ventricular ejection fraction (LVEF), and N-terminal probrain
natriureticpeptide(NT-proBNP),residualrenalfunction(MDRD),
and walking distance after the initiation of peritoneal dialysis
treatment. (b) Time course of bioimpedance measurement with
the Body Composition Monitor regarding hyperhydration, body-
weight, lean tissue mass, and fat tissue mass after the initiation of
peritoneal dialysis treatment.
kidney function with a clearance of 26mL/min/1.73m
(MDRD).
AT e n c k h o ﬀ catheter was implanted without complica-
tions to start peritoneal dialysis in 06/08 with 9.5L phys-
ioneal 1.36% and 1.5L extraneal using automated peritoneal
dialysis (APD).
As a clear result, the bodyweight was signiﬁcantly re-
duced, including reaching consecutive cardiac recompen-
sation. The bioimpedance measurement using the Body
Composition Monitor system (Fresenius Medical Care, Bad
Homburg, Germany) showed a rigorous reduction of hyper-
hydration and simultaneous increasing muscle mass and
body weight as treatment proceeded. At the same time, the
pulmonary artery pressure (PAP) was signiﬁcantly reduced.
The initial high-level NT-pro-BNP parameter decreased
withintheﬁrstweeksofdialysisaswellasbecomingstabilised
during the whole treatment (see Figure 1).
An improved general condition and good acceptance of
peritoneal dialysis were seen when the patient underwent the
regular reassessments. The residual diuresis was quantiﬁed
with 1.5L with a Kt/V quality of 2.8 (1.4 renal and 1.4 peri-
toneal).
A successful APD treatment-free interval was initiated
in 12/10, showing adequate diuresis and stable retention
parameters leading to catheter removal in 03/11. Heart func-
tion was stable til 06/11, the calculated eGFR (MDRD) in-
creasedfrom39.2mL/min/1.73matthetimepointofPDces-
sation to 51.8mL/min/1.73m 06/11, and the possible walk-
ing distance increased up to kilometres walking the dog. Ac-
tually the patient is not listed for heart transplantation due
to the clinical improvement.
3. Discussion
In this case, there was a cardiorenal syndrome type 2 includ-
ing interference of advanced congestive heart failure with
kidney function. The peritoneal dialysis treatment demon-
strated its opportunity to impact on both heart and kidney.
Despite comorbidities, heart transplantation was taken into
account. After repeated hydropic decompensation despite
optimised conservativemedicaltreatment,therewascertain-
ly need for an alternative therapeutic approach. Peritoneal
dialysis permitted not only the examination of capacity
and cardiac recompensation, but also a recompensation of
renal function. As this case shows, peritoneal dialysis of-
fers a therapeutic option, at least in patients waiting for
heart transplantation or for patients not possible for heart
transplantation. The opportunity of an intermittent treat-
ment with a subsequent abrogation of peritoneal dialysis
treatment underlines the importance of ﬂuid balance in
these patients, which can be achieved by peritoneal dialysis
and monitored with bioimpedance measurement.
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